There are several theoretical mechanisms by which a mutation at two or more distinct loci might give rise to clinically similar diseases, but relatively few examples have so far been found. The best chance of identifying such loci, if both are autosomal, exists when the mildness of the disorder allows the collection of large families or when candidate loci can be suggested for direct testing.
the former was the earlier demonstration of two forms of elliptocytosis distinguished at that time only by the presence or absence of linkage to the rhesus blood group. Osteogenesis imperfecta, caused by mutation at one of two Type I collagen genes, is an example of the successful application of the second approach.2 Recently locus heterogeneity was also demonstrated for a number of other diseases.
Although tuberous sclerosis (TSC) has very variable severity, there was no a priori reason to suppose that it would show locus heterogeneity, because the clinical impression is that variation within families is as great as that between families. However, as detailed elsewhere at this conference,' conflicting evidence has led to the suggestion that at least two genes determine TSC: TSCl on chromosome 9 and TSC2 on chromosome I I . In this report we present two attempts to analyze, by pairwise methods, exactly the same data as those analyzed by Janssen.
MATERIALS AND METHODS
Seventy-four families were considered in total, the sources being London, Cardiff, Rotterdam, Irvine, and Boston. The identification of families by source does not imply the origin of the families, only that of the researchers. Details of some of these families have previously been published.a Because of possibly different criteria used for diagnosis of nonaffected individuals at risk, penetrance was set at the level used in the laboratory of origin of the data. Pairwise analysis was done by LIPED or the Linkage package as determined by the data format. Data were not factored by sex. In both approaches described herein, selection of families to be analyzed for markers on chromosome 9 or I 1 was followed by conventional two-point analysis and multiple two-point analysis using the program MAP90.9 In making the maps and in placing TSC, interference was allowed for a mapping parameter of 0.35. The pairwise lodscores between the markers used for construction of the maps were taken from published datalo." and also derived from Julier (personal communication).
Negative Lodscore Method
The first approach, described elsewhere,I? uses linkage data from a candidate chromosome only if the alternative chromosome in that family is associated with negative lodscores. For a selected group of loci on each chromosome, thought to be close to the putative TSC genes, sex-pooled lodscores at 0 = 0.1 were calculated. For each family, lodscores for each locus on chromosome 9 were added together, and the same was done for chromosome 11. In an initial calculation using a program provided by John Edwards, the overall sum of the lodscores for each chromosome was obtained before and after dividing the families as just described. In an effort to estimate the most likely positions of the putative TSCl and TSC2, only those families in which a lodscore more negative than -0.3 was obtained were selected for detailed analysis of markers from the other chromosome. The advantage of this method was seen as its lack of bias; the value of 8 and the threshold to be used were selected before the calculation was started.
Maximum Lodscore Method
The second method uses the maximum lodscores from both candidate chromosomes to classify the families (Newton Morton, personal communication). If ZO is the sum of all maximum lods for m informative loci in a given pedigree and ZE is the sum evaluated at the correct map distance, large-sample theory predicts that 2 (In 10) (Zo -ZE) should be distributed as xk,, the expected value of which is m -I . Then a reasonable estimate of ZE is Zom -1/21n10. The same equation would apply to a family with linkage to m' loci on another chromosome. Thus, S = Zo -ZI0 + (m' -m)/21n10 is a lod for separating the two classes. A positive value suggests linkage to the first chromosome (9) and a negative value to the second (I I). To avoid problems from small families and the possibility that in some families TSC is not linked to either chromosome, a threshold value for S of 0.43 (positive or negative) was used. This corresponds to odds of 2.7 : 1 and to Akaike's criterion of x2 = 2.
RESULTS

Negative Lodscore Method
Preliminary analysis of the families gave encouraging results, summarized in TABLE 1. Fifty-three families had at least a small amount of data for both chromosomes 9 and 1 I. Of those, 21 were positive for 9 and negative for 1 I, 18 were positive for 1 1 and negative for 9, 2 were positive for both, and 12 were negative for both. On the basis of the more stringent criteria previously decided upon, 30 families were selected for analysis of 9 markers and 24 for I I markers, 8 families being included in both analyses. TABLE 2, column I, lists the individual families selected by this method. TABLES 3 and 4 show maximum lodscores, and FIGURES 1 and 2 show the most likely positions of TSCl and TSC2 obtained from these data. I I I I ABBREVIATIONS: NEG = families selected for analysis with 9 andlor I I markers by negative lodscore approach; MAX = separation of families by maximum lodscore approach; IC = results from imaginary chromosome approach.' Rot = Rotterdam. Car = Cardiff, Irv = Irvine, Lon = London, and Bos = Boston. maximum lodscores obtained in selected families are again given in TABLES 3 and 4, with the most likely map positions of TSCl and TSC2 in FIGURES 1 and 2.
Maximum Lodscore Method
DISCUSSION
Progress in understanding and in possibly preventing TSC would be greatly helped by a single localization for the disease gene. Unfortunately it now seems beyond reasonable doubt that this is not the case and that a solution to the problem of locus heterogeneity must be found. Each approach used by ourselves and others to analyze the available data has some good and bad points. It is not appropriate to discuss all the theoretical aspects here. However, in summary the negative lodscore approach, although not claiming great precision in selection of families, is entirely free from bias. The maximum lodscore method does not require a knowledge of marker order or distance, or the proportion of families FIGURE 2 . Pairwise lodscores from I I loci extending from DI IS84 to DI IS147 were used to make a basic genetic map.
The urrows indicate the best intervals in which TSC2 can be fitted by the negative lodscore method and by the maximum lodscore method. TSCZ could not be excluded with odds of greater than 10: I from the regions defined by the bars. linked to a particular chromosome. The imaginary chromosome method is powerful and was able to classify a higher percentage of the families than w a s either of the other approaches. However, it is very dependent on the precise basic map used and is vulnerable (as is the negative lodscore method) to problems arising from further heterogeneity. With all these problems it is encouraging that a large measure of agreement exists between the methods. Substantial agreement also exists with results obtained by HainesI3 using a larger combined data set which includes all the families described herein. In all cases evidence is strong that a locus TSCl is present on chromosome 9 and that the most likely position is near ABL, although a position slightly distal to ABO cannot be excluded. In about an equal number of families there is evidence for a locus on Chromosome 1 I. Although the data from Irvine, taken alone,8 provide convincing evidence for the existence of a locus on Chromosome 1 1 , over the whole data set (as evidenced by the lodscores in TABLES 3 and 4) the support for this locus is not as unequivocal as that for TSCl on chromosome 9. The best position for TSC2 by both pairwise approaches is in the region of DI IS132, proximal to DI IS144 (MCT128) and distal to DI IS35; this is only marginally preferred to a position distal to PBGD. By the imaginary chromosome approach the best positions for TSC are either proximal or distal to the whole set of markers, reflecting a lack of critical recombinants indicating position. However, in this analysis the markers used included only PBGD. DI IS29. DllS351. and DllS144; thus, a localization of TSC proximal to this set of markers is consistent with the localization by MAP90 with the negative lodscore method or the maximum lodscore method. Of course. the possibility of a third locus cannot be excluded. This might have a greater effect on chromosome I I data than on chromosome 9 data for artefactual reasons. At least in the London data set many more markers on chromosome 9 than on 1 I have been tested: hence a family in which TSC has been excluded from a long section of chromosome 9 may be allocated for analysis on chromosome 1 I despite the fact that whatever information is available for markers on Chromosome l l is negative.
Those families that appear to have negative lodscores for both chromosomes are clearly of crucial importance. They are good families in which to look for a third locus; alternatively they may contain critically important recombinants. There are four families in this category in the London data. In one of the families the recombination is dependent on the correct diagnosis of a fully investigated 25year-old adult as unaffected. In the three other families the negative scores do not depend on unaffected members. but in all three only a limited number of markers on chromosome 1 I have been tested. so that assignment of TSC to Chromosome I 1 in these families cannot be entirely excluded.
FUTURE PROSPECTS
The collection of new large families well characterized for tuberous sclerosis and the generation of many new markers o n 9q34 and I lq23 would be desirable. However, even with the material available, a major limitation of the analysis was that so few families have been typed for a good range of available markers on each chromosome. The laboratories participating in this collaboration have agreed to make every effort to test all families for markers ABL, ABO, A K I , MCT126, MCOA12, and ASS on chromosome 9. and CR1424, DI IS35, MCT128, APOA4. CJ52.208, DI IS29, and PBGD on chromosome I I . It would also be of interest for experienced clinicians to see if, with the powerful tool of hindsight, any differences can be detected in those families showing linkage to different Chromosome regions.
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